A recent study reveals that individuals who come off new GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who stop traditional diet and exercise programs.
Published data in a prominent health publication points out that while overweight people often shed substantial amounts of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing these drugs should be aware of the danger of fast weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.
That rate of regain suggests a return to pre-treatment mass in about 18 months.
Weighing Approaches
The study, which reviewed dozens of trials involving thousands of patients, compared the effects of these new drugs with other pills.
Researchers emphasize that individuals who shed pounds through dieting generally have a slower creep back—around 0.1 kg a month—once they finish.
Understanding the Fast Rebound
Doctors propose the way of the jabs explains the amplified rebound.
These medications copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication leads to hunger is uncontrolled, making binge eating much more probable."
A Chronic Issue?
Medical guidelines suggest the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians contend that, due to the likelihood of weight regain, the therapy is often long-term.
This perspective is supported by pharmaceutical companies, who note that the findings "underscore the persistent character of obesity," comparing it to managing diseases like high blood pressure.
User Testimonies
People who have stopped the medication report a powerful return of cravings.
"It was like a trigger that goes on and I was suddenly ravenous," said one woman.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit changes during therapy.
Widespread Use
Recent estimates indicate that a significant number of adults in the UK have used these injections in the last 12 months, with demand being substantial.
- Use is higher among women than men.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, experts stress that while these medications are potent agents for weight loss, they are not a permanent fix and long-term success relies on integrated lifestyle changes.
